About
RegenLab USA specializes in regenerative medicine and platelet-rich plasma (PRP) solutions. Founded in 2003, it is a subsidiary of the global Regen Lab group and is headquartered in New York City. The company has a manufacturing facility in New York State and a new R&D facility in Jersey City, New Jersey, enhancing its presence in the U.S. life sciences sector. The company develops high-quality medical devices for autologous cellular preparations at the point of care. Its flagship products include the patented RegenKit devices and autologous platelet-rich plasma (A-PRP) solutions, which are utilized in various medical fields such as musculoskeletal disorders, dermatology, wound care, and intimate health. RegenLab USA serves a diverse customer base, including aesthetic doctors, orthopedic surgeons, and veterinarians, and has treated over 2 million patients globally. The company adheres to rigorous quality standards and holds certifications like ISO 13485 and CE marking, ensuring safety and effectiveness in its offerings.
Technologies
Keywords
Company Information
-
Employees 46
-
Founded 2013
-
Annual Revenue $6000000
Location
95 Greene St, Jersey City, New Jersey, United States, 07302-3815
